Myriad Genetics (MYGN) has launched a new educational website providing comprehensive information about reproductive and prenatal genetic testing. The “Know More Sooner” website provides the benefits and dispels the common myths of prenatal genetic testing, as well as where to get screened and what actions can be taken in the instance of a high-risk result. The site features real-life patient stories to illustrate how prenatal screening can help parents-to-be manage their pregnancies.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MYGN:
- Myriad Genetics announces hereditary cancer risk assessment study published
- Myriad Genetics sees Q4 adjusted EPS 3c-4c, consensus 3c
- Myriad Genetics sees FY24 adjusted EPS 14c-15c, consensus 13c
- Myriad Genetics sees FY25 adjusted EPS 7c-11c, consensus 9c
- Myriad Genetics, MD Anderson forms 5-year strategic alliance